A Clinical Trial for the Interventional Robotic System

Clinical Trial Summary

The goal of this multi-center clinical trial is to evaluate the efficacy and safety of the interventional robotic system for cerebral angiography, researchers will compare the ordinary angiography to assess the clinical success rate, operation time, radiation absorption, etc.

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05401669` - Transradial Versus Transfemoral Arterial Access for Cerebral Angiography	N/A
Completed	`NCT06365398` - Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy	Phase 4
Not yet recruiting	`NCT03566628` - Post-anaesthetic Shivering Amongst Patients Undergoing Cerebral Angiography	N/A
Recruiting	`NCT04477031` - Verification of the Safety of Normal Food Before a Cerebral Arteriography

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT05401669 - Transradial Versus Transfemoral Arterial Access for Cerebral Angiography

N/A

Completed

NCT06365398 - Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy

Phase 4

Not yet recruiting

NCT03566628 - Post-anaesthetic Shivering Amongst Patients Undergoing Cerebral Angiography

N/A

Recruiting

NCT04477031 - Verification of the Safety of Normal Food Before a Cerebral Arteriography

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05778214
Study type	Interventional
Source	Changhai Hospital
Contact
Status	Recruiting
Phase	N/A
Start date	February 28, 2023
Completion date	December 2024

A Clinical Trial for the Interventional Robotic System

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms